Table 2.
(n=1810) | OR | 95% CI | P-value |
---|---|---|---|
Ileal involvement (L1+L3) | 3.18 | 2.23 -4.64 | <0.001 |
Disease duration (decade) | 1.33 | 1.19-1.49 | <0.001 |
L4-jejunal (vs. non-L4) | 2.90 | 1.89-4.45 | <0.001 |
Age at diagnosis (decade) | 1.21 | 1.10-1.34 | <0.001 |
Hispanic Ethnicity | 1.57 | 0.87-2.84 | 0.13 |
L4-EGD (vs. non-L4) | 0.82 | 0.51-1.28 | 0.39 |
African American race | 1.34 | 0.68-2.63 | 0.40 |
Caucasian race | 1.19 | 0.66-2.16 | 0.57 |
Female | 1.03 | 0.82-1.29 | 0.82 |
Family history of IBD | 1.01 | 0.73-1.33 | 0.90 |
Smoking at diagnosis | 1.01 | 0.77-1.33 | 0.93 |
Rows sorted by significance of estimation.
Level of significance – p<0.01.
OR – odds ratio; CI – confidence interval; IBD - inflammatory bowel disease; EGD - esophagogastroduodenal